A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Cardiovascular effects of premedication with medetomidine alone and in combination with MK-467 or glycopyrrolate in dogs subsequently anesthetized with isoflurane
Tekijät: Salla KM, Tuns CI, Bennett RC, Raekallio MR, Scheinin M, Kuusela E, Vainio OM
Kustantaja: AMER VETERINARY MEDICAL ASSOC
Julkaisuvuosi: 2017
Journal: American Journal of Veterinary Research
Tietokannassa oleva lehden nimi: AMERICAN JOURNAL OF VETERINARY RESEARCH
Lehden akronyymi: AM J VET RES
Vuosikerta: 78
Numero: 11
Aloitussivu: 1245
Lopetussivu: 1254
Sivujen määrä: 10
ISSN: 0002-9645
eISSN: 1943-5681
DOI: https://doi.org/10.2460/ajvr.78.11.1245
Tiivistelmä
OBJECTIVETo compare cardiovascular effects of premedication with medetomidine alone and with each of 3 doses of MK-467 or after glycopyrrolate in dogs subsequently anesthetized with isoflurane.ANIMALS8 healthy purpose-bred 5-year-old Beagles.PROCEDURESIn a randomized crossover study, each dog received 5 premedication protocols (medetomidine [10 mu g/kg, IV] alone [MED] and in combination with MK-467 at doses of 50 [MMK50], 100 [MMK100], and 150 [MMK150] mu g/kg and 15 minutes after glycopyrrolate [10 mu g/kg, SC; MGP]), with at least 14 days between treatments. Twenty minutes after medetomidine administration, anesthesia was induced with ketamine (0.5 mg/kg, IV) and midazolam (0.1 mg/kg, IV) increments given to effect and maintained with isoflurane (1.2%) for 50 minutes. Cardiovascular variables were recorded, and blood samples for determination of plasma dexmedetomidine, levomedetomidine, and MK-467 concentrations were collected at predetermined times. Variables were compared among the 5 treatments.RESULTSThe mean arterial pressure and systemic vascular resistance index increased following the MED treatment, and those increases were augmented and obtunded following the MGP and MMK150 treatments, respectively. Mean cardiac index for the MMK100 and MMK150 treatments was significantly greater than that for the MGP treatment. The area under the time-concentration curve to the last sampling point for dexmedetomidine for the MMK150 treatment was significantly lower than that for the MED treatment.CONCLUSIONS AND CLINICAL RELEVANCEResults indicated concurrent administration of MK-467 with medetomidine alleviated medetomidine-induced hemodynamic changes in a dose-dependent manner prior to isoflurane anesthesia. Following MK-467 administration to healthy dogs, mean arterial pressure was sustained at acceptable levels during isoflurane anesthesia.
OBJECTIVETo compare cardiovascular effects of premedication with medetomidine alone and with each of 3 doses of MK-467 or after glycopyrrolate in dogs subsequently anesthetized with isoflurane.ANIMALS8 healthy purpose-bred 5-year-old Beagles.PROCEDURESIn a randomized crossover study, each dog received 5 premedication protocols (medetomidine [10 mu g/kg, IV] alone [MED] and in combination with MK-467 at doses of 50 [MMK50], 100 [MMK100], and 150 [MMK150] mu g/kg and 15 minutes after glycopyrrolate [10 mu g/kg, SC; MGP]), with at least 14 days between treatments. Twenty minutes after medetomidine administration, anesthesia was induced with ketamine (0.5 mg/kg, IV) and midazolam (0.1 mg/kg, IV) increments given to effect and maintained with isoflurane (1.2%) for 50 minutes. Cardiovascular variables were recorded, and blood samples for determination of plasma dexmedetomidine, levomedetomidine, and MK-467 concentrations were collected at predetermined times. Variables were compared among the 5 treatments.RESULTSThe mean arterial pressure and systemic vascular resistance index increased following the MED treatment, and those increases were augmented and obtunded following the MGP and MMK150 treatments, respectively. Mean cardiac index for the MMK100 and MMK150 treatments was significantly greater than that for the MGP treatment. The area under the time-concentration curve to the last sampling point for dexmedetomidine for the MMK150 treatment was significantly lower than that for the MED treatment.CONCLUSIONS AND CLINICAL RELEVANCEResults indicated concurrent administration of MK-467 with medetomidine alleviated medetomidine-induced hemodynamic changes in a dose-dependent manner prior to isoflurane anesthesia. Following MK-467 administration to healthy dogs, mean arterial pressure was sustained at acceptable levels during isoflurane anesthesia.
Turun yliopiston Tutkimustietojärjestelmän portaali